Cytokine-Based Cancer Immunotherapies Summit Boston | Hyatt Regency Boston, MA
Evvnt Promotion / evvnt
Archiv
30.11.2021 - 02.12.2021 Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 8:20 am - 5:00 pm
Kongressthemen
Welcome to the only in person dedicated industry forum supporting the development of robust cytokine-based cancer immunotherapy platforms (cytokine muteins, antibody-cytokine fusion proteins (immunokines), anticancer vaccines, and cancer-directed antibodies) to deliver targeted, durable therapeutic interventions to solid tumor and hematological cancer indications.
Welcome to the only in person dedicated industry forum supporting the development of robust cytokine-based cancer immunotherapy platforms (cytokine muteins, antibody-cytokine fusion proteins (immunokines), anticancer vaccines, and cancer-directed antibodies) to deliver targeted, durable therapeutic interventions to solid tumor and hematological cancer indications.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/850076-3?pid=4832
Speakers: Dario Neri, Co-CEO and CSO, Professor, Philogen and ETH Zurich, Khursheed Anwer, Chief Scientific Officer and Executive Vice President, Celsion and more
Brochure: https://go.evvnt.com/850076-3?pid=4832
Speakers: Dario Neri, Co-CEO and CSO, Professor, Philogen and ETH Zurich, Khursheed Anwer, Chief Scientific Officer and Executive Vice President, Celsion and more
Anfragen und Anmeldung:
https://go.evvnt.com/850076-1?pid=4832
Frau Emily Birt
Allgemeinmedizin, Onkologie
Sprache
Englisch
Englisch
Kongressgebühr
USD 2599.00 - USD 4797.00
USD 2599.00 - USD 4797.00
Teilnehmer erwartet
1000
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
